These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
221 related articles for article (PubMed ID: 10089303)
21. A mammalian protein targeted by G1-arresting rapamycin-receptor complex. Brown EJ; Albers MW; Shin TB; Ichikawa K; Keith CT; Lane WS; Schreiber SL Nature; 1994 Jun; 369(6483):756-8. PubMed ID: 8008069 [TBL] [Abstract][Full Text] [Related]
22. FK506 binding protein 12 mediates sensitivity to both FK506 and rapamycin in murine mast cells. Fruman DA; Wood MA; Gjertson CK; Katz HR; Burakoff SJ; Bierer BE Eur J Immunol; 1995 Feb; 25(2):563-71. PubMed ID: 7533090 [TBL] [Abstract][Full Text] [Related]
23. Rapamycin exerts antifungal activity in vitro and in vivo against Mucor circinelloides via FKBP12-dependent inhibition of Tor. Bastidas RJ; Shertz CA; Lee SC; Heitman J; Cardenas ME Eukaryot Cell; 2012 Mar; 11(3):270-81. PubMed ID: 22210828 [TBL] [Abstract][Full Text] [Related]
24. The FKBP-rapamycin binding domain of human TOR undergoes strong conformational changes in the presence of membrane mimetics with and without the regulator phosphatidic acid. Rodriguez Camargo DC; Link NM; Dames SA Biochemistry; 2012 Jun; 51(24):4909-21. PubMed ID: 22620485 [TBL] [Abstract][Full Text] [Related]
25. The rapamycin-binding domain of the protein kinase mammalian target of rapamycin is a destabilizing domain. Edwards SR; Wandless TJ J Biol Chem; 2007 May; 282(18):13395-401. PubMed ID: 17350953 [TBL] [Abstract][Full Text] [Related]
26. Protein phosphatase 2A interacts with the 70-kDa S6 kinase and is activated by inhibition of FKBP12-rapamycinassociated protein. Peterson RT; Desai BN; Hardwick JS; Schreiber SL Proc Natl Acad Sci U S A; 1999 Apr; 96(8):4438-42. PubMed ID: 10200280 [TBL] [Abstract][Full Text] [Related]
32. Control of p70 s6 kinase by kinase activity of FRAP in vivo. Brown EJ; Beal PA; Keith CT; Chen J; Shin TB; Schreiber SL Nature; 1995 Oct; 377(6548):441-6. PubMed ID: 7566123 [TBL] [Abstract][Full Text] [Related]
33. Rapamycin analogs with differential binding specificity permit orthogonal control of protein activity. Bayle JH; Grimley JS; Stankunas K; Gestwicki JE; Wandless TJ; Crabtree GR Chem Biol; 2006 Jan; 13(1):99-107. PubMed ID: 16426976 [TBL] [Abstract][Full Text] [Related]
34. Crystal structures of human calcineurin and the human FKBP12-FK506-calcineurin complex. Kissinger CR; Parge HE; Knighton DR; Lewis CT; Pelletier LA; Tempczyk A; Kalish VJ; Tucker KD; Showalter RE; Moomaw EW Nature; 1995 Dec; 378(6557):641-4. PubMed ID: 8524402 [TBL] [Abstract][Full Text] [Related]
35. Conditional protein splicing: a new tool to control protein structure and function in vitro and in vivo. Mootz HD; Blum ES; Tyszkiewicz AB; Muir TW J Am Chem Soc; 2003 Sep; 125(35):10561-9. PubMed ID: 12940738 [TBL] [Abstract][Full Text] [Related]
36. Rapamycin blocks sexual development in fission yeast through inhibition of the cellular function of an FKBP12 homolog. Weisman R; Finkelstein S; Choder M J Biol Chem; 2001 Jul; 276(27):24736-42. PubMed ID: 11335722 [TBL] [Abstract][Full Text] [Related]
37. The FRB domain of mTOR: NMR solution structure and inhibitor design. Leone M; Crowell KJ; Chen J; Jung D; Chiang GG; Sareth S; Abraham RT; Pellecchia M Biochemistry; 2006 Aug; 45(34):10294-302. PubMed ID: 16922504 [TBL] [Abstract][Full Text] [Related]
38. 14-3-3tau associates with a translational control factor FKBP12-rapamycin-associated protein in T-cells after stimulation by pervanadate. Mori H; Inoue M; Yano M; Wakabayashi H; Kido H FEBS Lett; 2000 Feb; 467(1):61-4. PubMed ID: 10664457 [TBL] [Abstract][Full Text] [Related]
39. Design and structure-based study of new potential FKBP12 inhibitors. Sun F; Li P; Ding Y; Wang L; Bartlam M; Shu C; Shen B; Jiang H; Li S; Rao Z Biophys J; 2003 Nov; 85(5):3194-201. PubMed ID: 14581219 [TBL] [Abstract][Full Text] [Related]